ALTERRIS Trademark

Trademark Overview

On Thursday, June 25, 2026, a trademark application was filed for ALTERRIS with the United States Patent and Trademark Office. The USPTO has given the ALTERRIS trademark a serial number of 99905043. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 25, 2026. This trademark is owned by Alterris Oncology, Inc.. The ALTERRIS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of cancer and oncology
alterris

General Information

Serial Number99905043
Word MarkALTERRIS
Filing DateThursday, June 25, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, June 25, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical testing for diagnostic or treatment purposes; Medical diagnostic testing, monitoring and reporting services; Medical testing for diagnostic or treatment purposes in the field of cancer and oncology

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 25, 2026
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlterris Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestwood, MA 02090
US

Trademark Events

Event DateEvent Description
Thursday, June 25, 2026NEW APPLICATION ENTERED
Thursday, June 25, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

alterris medical diagnostic testing purposes treatment cancer oncology field monitoring reporting